Thursday, December 12

Healthcare

Xencor stock rallies 24% amid drug development updates

09/10/20241 Min Read

Development drug rallies stock Updates Xencor

Previous ArticleRelay Therapeutics announces proposed public offering of common stock

Next Article Summit a ‘top pick’ at Citi after ‘unprecedented’ trial outcomes, bull rally